Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Xu Stella, Director. Insider active across 2 companies, notably Millendo Therapeutics, Inc.. In total, 3 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €9.5m. History available since 18 March 2022. The latest transaction was disclosed on 18 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Stella Xu is a Board Member at Millendo Therapeutics, Inc. and Design Therapeutics, Inc. She contributes to the governance of these companies by participating in strategic decision-making and overseeing operations. Xu is recognized for her expertise in the biopharmaceutical sector.